OTC · HMPSF
The Hempshire Group, Inc.
$0.19$0.00 (0.0%)
The Hempshire Group, Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
Loading market information…
OTC · PKANF · USD
Stock price, earnings
Quote as of Oct 25, 2023, 06:15 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Simply Better Brands Corp.’s quoted price sits in the lower half of its reported 52-week range, 54.04% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Simply Better Brands Corp.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Simply Better Brands Corp. (SBB) is a Canadian-based enterprise that specializes in the production and distribution of hemp-derived cannabidiol (CBD) products, primarily serving the United States market. Its diverse product portfolio encompasses a wide array of CBD-infused items, including tinctures, topical applications, capsules, edible gummies, and a dedicated line for pets featuring tinctures, treats, and other wellness solutions. SBB also offers bath bombs and a comprehensive range of skincare products, such as caffeine eye cream, retinol night cream, charcoal peel-off masks, moisturizers, serums, toner, cleanser, and acne patches. Additionally, the company provides nutritious snack bars. These offerings are marketed under various proprietary brands, including PureKana, Tru Brand, BudaPets, and No BS. Simply Better Brands Corp. reaches its customers through both its own e-commerce platforms and traditional brick-and-mortar retail outlets. Founded in 2017, the company initially operated as PureK Holdings Corp. before rebranding to Simply Better Brands Corp. in May 2021. Headquartered in Vancouver, Canada, SBB functions as a subsidiary of Heavenly Rx Ltd.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 10:33 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.19$0.00 (0.0%)
The Hempshire Group, Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.82+$0.78 (+2,173.99%)
Titan Medical Inc.’s quoted price sits in the upper half of its reported 52-week range, 18.25% below the high.
$2.11+$0.11 (+5.5%)
Progressive Care, Inc.’s quoted price sits in the lower half of its reported 52-week range, 53.11% below the high.
$0.27+$0.01 (+2.88%)
MGC Pharmaceuticals Limited’s quoted price sits in the lower half of its reported 52-week range, 94.75% below the high.
$0.08$0.00 (0.0%)
RIV Capital Inc.’s quoted price sits in the lower half of its reported 52-week range, 52.66% below the high.
A$0.05A$0.00 (0.0%)
Noxopharm Limited’s quoted price sits in the lower half of its reported 52-week range, 55.45% below the high.
€0.17-€0.00 (-1.98%)
Poxel S.A.’s quoted price sits in the lower half of its reported 52-week range, 65.0% below the high.
CA$0.02CA$0.00 (0.0%)
Red White & Bloom Brands Inc.’s quoted price sits in the lower half of its reported 52-week range, 66.67% below the high.
